Semi-Annual Statement Of Income

Kringle Pharma,Inc. - Filing #7609492

Concept 2021-10-01 to
2022-03-31
2020-10-01 to
2021-03-31
Semi-annual statement of income
Statement of income
Net sales
27,300,000 JPY
117,825,000 JPY
Cost of sales
JPY
JPY
Ordinary profit (loss)
-318,965,000 JPY
-191,777,000 JPY
Gross profit (loss)
27,300,000 JPY
117,825,000 JPY
Selling, general and administrative expenses
338,006,000 JPY
287,331,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-318,965,000 JPY
-191,777,000 JPY
Operating profit (loss)
-310,706,000 JPY
-169,505,000 JPY
Income taxes - current
745,000 JPY
745,000 JPY
Non-operating income
239,000 JPY
618,000 JPY
Non-operating income
Income taxes
745,000 JPY
745,000 JPY
Non-operating expenses
8,497,000 JPY
22,890,000 JPY
Profit (loss)
-319,710,000 JPY
-192,522,000 JPY
Non-operating expenses

Talk to a Data Expert

Have a question? We'll get back to you promptly.